SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-21-182059
Filing Date
2021-06-04
Accepted
2021-06-04 07:38:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC14D9C d350376dsc14d9c.htm SC14D9C 7481
2 EX-99.1 d350376dex991.htm EX-99.1 7991
3 GRAPHIC g350376capture.jpg GRAPHIC 39895
  Complete submission text file 0001193125-21-182059.txt   66751
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filed by) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Subject) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-90572 | Film No.: 21994871
SIC: 2834 Pharmaceutical Preparations